1st Circ. Nexium Case May Ripple Beyond Pharma

The First Circuit is set to hear arguments Thursday about whether a group of consumers, insurers and others who paid for Nexium can sue as a class over alleged pay-for-delay deals...

Already a subscriber? Click here to view full article